Have the organisms that cause breast abscess changed with time?-Implications for appropriate antibiotic usage in primary and secondary care

Breast Journal

Volumn 16, Issue 4, 2010, Pages 412-415

  Dabbas, Natalie ^a   Chand, Manish ^a   Pallett, Ann ^a   Royle, Gavin T ^a   Sainsbury, Richard ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Bacteria; Breast abscess; Methicillin resistant staphylococcus aureus

Indexed keywords

DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BREAST ABSCESS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLIFORM BACTERIUM; CORYNEBACTERIUM DIPHTHERIAE; FEMALE; FUSOBACTERIUM NUCLEATUM; GRAM NEGATIVE ANAEROBIC COCCI; HUMAN; LACTATION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PEPTOSTREPTOCOCCUS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS; STREPTOCOCCUS ANGINOSUS;

ABSCESS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 77956834013     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.00923.x     Document Type: Article

References (29)

1. Dixon JM. ABC of breast diseases: breast infection. BMJ 1994;309:946-949
2. Dener C, Inan A. Breast abscesses in lactating women. World J Surg 2003;27:130-133
3. Benson EA. Management of breast abscess. World J Surg 1989;13:753-756
4. Zylstra S. Office management of benign breast disease. Clin Obs Gynecol 1999;42:234-248
5. Li S, Grant CS, Degnim A, Donohue J. Surgical management of recurrent subareolar breast abscesses: mayo clinic experience. Am J Surg 2006;192:528-529
6. Versluijs-Ossewaarde FN, Roumen RM, Goris RJ. Subareolar breast abscesses: characteristics and results of surgical treatment. Breast J 2005;11:179-182
7. Scholefield JH, Duncan JL, Rogers K. Review of a hospital experience of breast abscesses. Br J Surg 1987;74:469-470
8. Goodman MA, Benson EA. An evaluation of the current trends in the management of breast abscess. Med J Austr 1970;1:1034.
9. Benson EA. Antibiotics in surgical treatment of septic lesions. Lancet 1970;1:1233.
10. Leach RD, Eykyn SJ, Phillips I, Corrin B. Anaerobic subareolar breast abscess. Lancet 1979;1:35-37
11. Hook GW, Ikeda DM. Treatment of breast abscesses with US-guided percutaneous needle drainage without indwelling catheter placement. Vasc and Intervent Radiol 1999;213:579-582
12. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Inf Dis 2001;7. Available at: http:// www.cdc.gov/ncidod/eid/vol7no2/chambers. html.
13. Moazzez A, Kelso RL, Towfigh S, Sohn H, Berne TV, Mason RJ. Breast abscess bacteriologic features in the era of community-acquired methicillin-resistant Staphylococcus aureus epidemics. Arch Surg 2007;142:881-884
14. Ferrara JJ, Leveque J, Dyess DL, Lorino CO. Nonsurgical management of breast infections in nonlactating women. A word of caution. Am Surg 1990;56:668-671
15. Walker AP, Edmiston CE, Krepel CJ, Condon RE. A prospective study of the microflora of nonpuerperal breast abscess. Arch Surg 1988;123:908-911
16. Edmiston CE, Walker AP, Krepel CJ, Gohr C. The nonpuerperal breast infection: aerobic and anaerobic microbial recovery from acute and chronic disease. J Infect Dis 1990;162:695-699
17. Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 2000;16:S3-10.
18. Paradisi F, Messeri D. Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics. Antibiot Ther 2001;85:1-17.
19. Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals. Clin Infect Dis 1999;29:245.
20. Abudu L, Blair I, Fraise A, Cheng KK. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001;126:351-356
21. Maudsley J, Stone SP, Kibbler CC, et al. The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK. J Hosp Infect 2004;57:258-262
22. Graninger W, Wenisch C, Hasenhuendl M. Treatment of staphylococcal infections. Curr Opin Infect Dis 1995;8(Suppl 1):20-28.
23. Diekema DI, Jones RN. Oxazolidinones: a review. Drugs 2000;59:7-16.
24. Bergogne-Berezin E. Resistance and new antibiotic strategies. New antistaphylococcal antibiotics. Presse Med 2000;29:2023-2027
25. Chien JW, Kucia ML, Salata RA. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. Clin Infect Dis 2000;31:146-151
26. Patel R, Rouse MS, Piper KE, Steckelberg JM. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin- resistant Staphylococcus aurues and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1999;34:119-122
27. Dresser LD, Rybak MJ. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials. Pharmacotherapy 1998;18:456-462
28. Brands M, Endermann R, Gahlmann R, Kruger J, Raddatz S. Dihydropyrimidinones - a new class of antistaphylococcal antibiotics. Bioorg Med Chem Lett 2003;13:241-245
29. Shittu A, Lin J. Newer antistaphylococcal agents: in vitro studies and emerging trends in staphylococcus aureus resistance. Wounds 2006;18:129-146